Capital Advisors Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.9M Buy
739,685
+106,104
+17% +$8.56M 0.85% 40
2026
Q1
$54.9M Sell
633,581
-5,707
-0.9% -$547K 0.88% 39
2025
Q4
$61.4M Buy
639,288
+49,060
+8% +$4.77M 0.99% 33
2025
Q3
$56.2M Buy
590,228
+117,590
+25% +$10.8M 0.94% 36
2025
Q2
$41.2M Buy
472,638
+19,180
+4% +$1.63M 0.74% 54
2025
Q1
$40.7M Buy
453,458
+121,185
+36% +$10.8M 0.81% 47
2024
Q4
$26.5M Buy
332,273
+16,242
+5% +$1.41M 0.53% 75
2024
Q3
$28.5M Buy
316,031
+11,708
+4% +$985K 0.57% 74
2024
Q2
$24M Buy
304,323
+9,132
+3% +$749K 0.49% 76
2024
Q1
$25.7M Buy
+295,191
New +$25.2M 0.55% 73

Other funds holding MDT

Capital Advisors Inc's MDT Position: Q2 2026 in Review

Capital Advisors Inc increased its Medtronic (MDT) stake by 17% in Q2 2026, buying an estimated $8.56M and bringing the position to 739,685 shares worth $57.9M. The position accounts for 0.85% of the portfolio, ranked #40.

Capital Advisors Inc first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $61.4M in Q4 2025. 2,133 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Capital Advisors Inc held 739,685 shares of Medtronic worth $57.9M as of Q2 2026.
  • Capital Advisors Inc bought 106,104 Medtronic shares in Q2 2026, an estimated $8.56M.
  • Medtronic made up 0.85% of Capital Advisors Inc's portfolio in Q2 2026, its #40 holding.
  • Capital Advisors Inc first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • Capital Advisors Inc's Medtronic position peaked at $61.4M in Q4 2025.
  • 2,133 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.